Semaglutide coverage for weight loss could cost Medicare billions: study
Healthcare Dive - Practice Management
AUGUST 27, 2024
If all newly eligible patients received semaglutide, Medicare Part D spending could increase by $34 billion to $145 billion each year, according to new research.
Let's personalize your content